CVRx, Inc. Common Stock (CVRX) Stock Price

CVRXStock

$1.30−86.33%52W

Market Cap$34.63M

P/E—

PEG Ratio—

Div yield—

Beta0.73

CVRX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-93.07%

Price vs S&P 500 (4W)-54.90%

VGM Score55.76

Book Value / Share (Quarterly)$0.75

P/TBV (Annual)3.82x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)36.10%

Cash Flow / Share (Quarterly)$-1.54

Price vs S&P 500 (YTD)-93.62%

Gross Margin (TTM)86.92%

Net Profit Margin (TTM)-84.92%

EPS (TTM)$-1.97

10-Day Avg Trading Volume0.55M

EPS Excl Extra (TTM)$-1.97

Revenue Growth (5Y)56.42%

EPS (Annual)$-2.04

ROI (Annual)-60.00%

Gross Margin (Annual)85.33%

Net Profit Margin (5Y Avg)-166.12%

Cash / Share (Quarterly)$2.42

Revenue Growth QoQ (YoY)15.57%

ROA (Last FY)-50.87%

Revenue Growth TTM (YoY)11.96%

EBITD / Share (TTM)$-1.82

ROE (5Y Avg)-68.33%

Operating Margin (TTM)-79.49%

Cash Flow / Share (Annual)$-1.55

P/B Ratio1.74x

P/B Ratio (Quarterly)6.84x

Net Income / Employee (Annual)$-239,000

EV / Revenue (TTM)0.47x

Net Interest Coverage (TTM)-8.15x

ROA (TTM)-50.93%

EPS Incl Extra (Annual)$-2.04

Current Ratio (Annual)7.63x

Quick Ratio (Quarterly)6.65x

3-Month Avg Trading Volume0.76M

52-Week Price Return-86.33%

Revenue / Employee (TTM)$274,400

Tangible BV / Share (Quarterly)$3.98

P/S Ratio (Annual)0.61x

Asset Turnover (Annual)0.54x

52-Week High$11.30

Operating Margin (5Y Avg)-137.77%

EPS Excl Extra (Annual)$-2.04

CapEx CAGR (5Y)13.35%

26-Week Price Return-83.16%

Quick Ratio (Annual)6.49x

13-Week Price Return-73.52%

Total Debt / Equity (Annual)1.26x

Current Ratio (Quarterly)8.04x

Enterprise Value$28.62M

Revenue / Share Growth (5Y)47.26%

Asset Turnover (TTM)0.60x

Revenue / Employee (Annual)$254,000

Inventory Turnover (Annual)0.68x

Pretax Margin (Annual)-94.13%

Cash / Share (Annual)$2.88

3-Month Return Std Dev154.15%

Gross Margin (5Y Avg)80.60%

Net Income / Employee (TTM)$-233,000

ROE (Last FY)-135.56%

Net Interest Coverage (Annual)-7.63x

EPS Basic Excl Extra (Annual)$-2.04

Receivables Turnover (TTM)7.39x

Total Debt / Equity (Quarterly)2.94x

EPS Incl Extra (TTM)$-1.97

Receivables Turnover (Annual)5.68x

ROI (TTM)-58.97%

P/S Ratio (TTM)0.57x

Pretax Margin (5Y Avg)-165.79%

Revenue / Share (Annual)$2.17

Tangible BV / Share (Annual)$5.29

Price vs S&P 500 (52W)-101.86%

Year-to-Date Return-81.69%

5-Day Price Return-12.16%

EPS Normalized (Annual)$-2.04

ROA (5Y Avg)-38.60%

Net Profit Margin (Annual)-94.10%

Month-to-Date Return-25.71%

Cash Flow / Share (TTM)$-2.03

EBITD / Share (Annual)$-1.94

Operating Margin (Annual)-90.49%

LT Debt / Equity (Annual)1.26x

ROI (5Y Avg)-42.85%

LT Debt / Equity (Quarterly)2.94x

EPS Basic Excl Extra (TTM)$-1.97

P/TBV (Quarterly)5.03x

P/B Ratio (Annual)4.73x

Inventory Turnover (TTM)0.65x

Pretax Margin (TTM)-84.94%

Book Value / Share (Annual)$1.49

Price vs S&P 500 (13W)-76.21%

Beta0.73x

Revenue / Share (TTM)$2.31

ROE (TTM)-152.34%

52-Week Low$1.25

vGradeA

gGradeB

mGradeF

vgmGradeC

CVRX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.52	-$0.53	-1.18%(-$0.01)
Q1 2026	May 11, 2026	-$0.50	-$0.50	+0.84%(+$0.00)
Q4 2025	Feb 12, 2026	-$0.44	-$0.46	-4.87%(-$0.02)
Q3 2025	Nov 5, 2025	-$0.50	-$0.49	+2.18%(+$0.01)
Q2 2025	Aug 4, 2025	-$0.52	-$0.57	-9.53%(-$0.05)

CVRX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

3.85

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
CVRXCVRx, Inc. Common Stock	A	B	F	0.6x	56.4%	86.9%	-79.5%	$1.30
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About CVRx, Inc. Common Stock

CVRx Inc is a commercial-stage medical device company developing minimally invasive neuromodulation solutions for heart failure and other cardiovascular diseases. Its proprietary Barostim platform uses Baroreflex Activation Therapy to restore autonomic nervous system balance and improve cardiac function. The company generates revenue primarily from the U.S. market.

CVRX Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.50

Revenue estimate$13.91M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

CVRX Insider Transactions

BuyAug 13, 2026
BINKOWSKI BRENT
Chief Operating Officer
Shares: 26,223Value: $76,432
SellAug 12, 2026
BINKOWSKI BRENT
Chief Operating Officer
Shares: 1,309Value: $3,338

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

PRPOPrecipio, Inc. Common StockLab Analytical Instruments
HBIOHarvard Bioscience IncLab Analytical Instruments
NNOXNANO-X IMAGING LTD Ordinary SharesX-Ray Equipment
QTIQT Imaging Holdings, Inc. Common StockElectromedical Equipment
BCHTBirchtech Corp.Measuring & Controlling Devices
MLSSMilestone Scientific, Inc. Common StockOrthopedic & Prosthetic Devices
ITOCiTonic Holdings Ltd Class A Ordinary SharesElectromedical Equipment
DAIOData I/O CorpInstruments for Measuring

Same SIC sector, outside this company's own industry.

Analyst Sentiment

3.9

Buy

Consensus rating

52-Week Range

Low$1.25

High$11.30